This matcher ranks tracked programs against four inputs: the dose you expect to maintain on, whether you want price to stay flat as you escalate, your monthly ceiling, and whether disclosure matters to you. It runs entirely in your browser.
It is a budgeting tool, not clinical advice, and it cannot tell you whether tirzepatide is appropriate for you. Only a clinician who has reviewed your history can do that.
Why this does not give you a score out of ten
A single editorial score compresses price, disclosure, service and clinical depth into one number and hides the weighting. We publish the inputs instead: the twelve-month cost at your dose, whether the price is flat, and a disclosure score whose formula is on the page. You can disagree with our weighting and recompute it — the dataset is downloadable.
What this matcher deliberately ignores
Service quality, shipping reliability and clinical depth are not in the ranking, because we do not have measurements of them that we would defend. Read the program review and the verification checklist before enrolling anywhere this tool surfaces.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.